A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy. [electronic resource]
Producer: 20040419Description: 275-8 p. digitalISSN:- 1464-4096
- Antineoplastic Agents -- therapeutic use
- Celecoxib
- Combined Modality Therapy
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors -- therapeutic use
- Drug Evaluation
- Follow-Up Studies
- Humans
- Isoenzymes -- antagonists & inhibitors
- Male
- Membrane Proteins
- Neoplasm Recurrence, Local -- drug therapy
- Pilot Projects
- Prostaglandin-Endoperoxide Synthases
- Prostate-Specific Antigen -- blood
- Prostatectomy
- Prostatic Neoplasms -- drug therapy
- Pyrazoles
- Sulfonamides -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.